Summary
For Year 2026-27, Sudeep Pharma reports the following shareholding: Total Promoters at 76.15%, Mutual Fund at 6.19%, Insurance at 1.16%, Foreign Institutional Investors at 1.55%, Domestic Institutional Investors at 10.76%, and Retail at 4.18%. This breakdown provides a quick snapshot of ownership distribution for Sudeep Pharma in 2026-27.
Sudeep Pharma FAQs
As of 04-2026, the promoter shareholding in Sudeep Pharma stands at 76.15% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Sudeep Pharma is 1.55% and 10.76% respectively.
The retail shareholding of the Sudeep Pharma is 4.18%.
Changes in shareholding patterns of Sudeep Pharma can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Sudeep Pharma are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
